Loading...

Yumi Mitsuya, MD

Title(s)Assistant Professor, Orthopaedic Surgery
SchoolSchool of Medicine
Address747 52nd Street
Oakland CA 94609
Phone510-428-3885 ext. 3016
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Albany Medical College, Albany, NYM.D.
    UCSF Benioff Children's Hospital Oakland, Oakland, CAResidency, Pediatrics
    Stanford University, Palo Alto, CAResidency, Physical Medicine and Rehabilitation

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1. Antimicrob Agents Chemother. 2013 Sep; 57(9):4290-4299. Varghese V, Mitsuya Y, Fessel WJ, Liu TF, Melikian GL, Katzenstein DA, Schiffer CA, Holmes SP, Shafer RW. PMID: 23796938.
      View in: PubMed   Mentions: 12     Fields:    
    2. Human immunodeficiency virus type 1 isolates with the reverse transcriptase (RT) mutation Q145M retain nucleoside and nonnucleoside RT inhibitor susceptibility. Antimicrob Agents Chemother. 2009 May; 53(5):2196-8. Varghese V, Mitsuya Y, Shahriar R, Bachmann MH, Fessel WJ, Kagan RM, Shafer RW. PMID: 19223644.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Minority human immunodeficiency virus type 1 variants in antiretroviral-naive persons with reverse transcriptase codon 215 revertant mutations. J Virol. 2008 Nov; 82(21):10747-55. Mitsuya Y, Varghese V, Wang C, Liu TF, Holmes SP, Jayakumar P, Gharizadeh B, Ronaghi M, Klein D, Fessel WJ, Shafer RW. PMID: 18715933.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    4. Viral population estimation using pyrosequencing. PLoS Comput Biol. 2008 May 09; 4(4):e1000074. Eriksson N, Pachter L, Mitsuya Y, Rhee SY, Wang C, Gharizadeh B, Ronaghi M, Shafer RW, Beerenwinkel N. PMID: 18437230.
      View in: PubMed   Mentions: 94     Fields:    Translation:Cells
    5. Prevalence of darunavir resistance-associated mutations: patterns of occurrence and association with past treatment. J Infect Dis. 2007 Oct 15; 196(8):1177-9. Mitsuya Y, Liu TF, Rhee SY, Fessel WJ, Shafer RW. PMID: 17955436.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    6. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res. 2007 Aug; 17(8):1195-201. Wang C, Mitsuya Y, Gharizadeh B, Ronaghi M, Shafer RW. PMID: 17600086.
      View in: PubMed   Mentions: 201     Fields:    Translation:HumansCells
    7. N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure. AIDS Res Hum Retroviruses. 2006 Dec; 22(12):1300-5. Mitsuya Y, Winters MA, Fessel WJ, Rhee SY, Hurley L, Horberg M, Schiffer CA, Zolopa AR, Shafer RW. PMID: 17209774.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    8. HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/mL. . 2006 Sep; 43(1):56-9. Mitsuya Y, Winters MA, Fessel WJ, Rhee SY, Slome S, Flamm J, Horberg M, Hurley L, Klein D, Shafer RW. PMID: 16885777.
      View in: PubMed   Mentions:
    9. A nitric oxide synthase inhibitor, N(G)-nitro-l-arginine-methyl-ester, exerts potent antiangiogenic effects on plasmacytoma in a newly established multiple myeloma severe combined immunodeficient mouse model. Br J Haematol. 2003 Feb; 120(3):396-404. Uneda S, Hata H, Matsuno F, Nagasaki A, Harada N, Mitsuya Y, Matsuzaki H, Mitsuya H. PMID: 12580953.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    10. Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM. Br J Haematol. 2003 Jan; 120(1):53-5. Uneda S, Hata H, Matsuno F, Harada N, Mitsuya Y, Kawano F, Mitsuya H. PMID: 12492576.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    Yumi's Networks
    Concepts (73)
    Derived automatically from this person's publications.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑